Efficacy of siltuximab in the treatment of idiopathic multicentric castleman disease, the first Polish, real-world experience with long-term observation

Autor:	Agnieszka Szymczyk, Marek Hus, Waldemar Tomczak, Beata Ostrowska, Sebastian Rybski, Anna Dąbrowska-Iwanicka, Tomasz Wróbel, Magdalena Olszewska-Szopa, Jan Walewski, Joanna Romejko-Jarosinska, Katarzyna Domanska-Czyz
Rok vydání:	2021
Předmět:	Cancer Research medicine.medical_specialty business.industry viruses Castleman disease Castleman Disease virus diseases Antibodies Monoclonal Hematology medicine.disease Dermatology Siltuximab chemistry.chemical_compound Oncology chemistry immune system diseases hemic and lymphatic diseases medicine Humans Poland Multicentric Castleman Disease business
Zdroj:	Leukemialymphoma. 62(12)
ISSN:	1029-2403
Popis:	Castleman disease (CD) was first described in the 1954 by Benjamin Castleman as a rare nonmalignant lymphoproliferative disorder [1]. Multicentric CD (MCD) involves multiple regions of enlarged lym...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0e18fbfe75b2dd7731957e187255c2c https://pubmed.ncbi.nlm.nih.gov/34159888 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.